See more : CannLabs, Inc. (CANL) Income Statement Analysis – Financial Results
Complete financial analysis of Population Health Investment Co., Inc. (PHICU) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Population Health Investment Co., Inc., a leading company in the Shell Companies industry within the Financial Services sector.
- Beijer Ref AB (publ) (BEIJ-B.ST) Income Statement Analysis – Financial Results
- Arcos Dorados Holdings Inc. (ARCO) Income Statement Analysis – Financial Results
- React Gaming Group Inc. (ITMZF) Income Statement Analysis – Financial Results
- Fair Isaac Corporation (0TIQ.L) Income Statement Analysis – Financial Results
- Wedge Holdings CO.,LTD. (2388.T) Income Statement Analysis – Financial Results
Population Health Investment Co., Inc. (PHICU)
Industry: Shell Companies
Sector: Financial Services
About Population Health Investment Co., Inc.
Population Health Investment Co., Inc. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.
Metric | 2021 | 2020 |
---|---|---|
Revenue | 0.00 | 0.00 |
Cost of Revenue | 0.00 | 0.00 |
Gross Profit | 0.00 | 0.00 |
Gross Profit Ratio | 0.00% | 0.00% |
Research & Development | 0.00 | 0.00 |
General & Administrative | 1.54M | 248.93K |
Selling & Marketing | 0.00 | 0.00 |
SG&A | 1.54M | 248.93K |
Other Expenses | 0.00 | 0.00 |
Operating Expenses | 1.54M | 248.93K |
Cost & Expenses | 1.54M | 248.93K |
Interest Income | 0.00 | 0.00 |
Interest Expense | -7.39M | 0.00 |
Depreciation & Amortization | 7.39M | 227.00 |
EBITDA | 5.86M | -248.71K |
EBITDA Ratio | 0.00% | 0.00% |
Operating Income | -1.54M | -248.93K |
Operating Income Ratio | 0.00% | 0.00% |
Total Other Income/Expenses | 7.39M | 227.00 |
Income Before Tax | 5.86M | -248.71K |
Income Before Tax Ratio | 0.00% | 0.00% |
Income Tax Expense | -7.39M | 0.00 |
Net Income | 13.25M | -248.71K |
Net Income Ratio | 0.00% | 0.00% |
EPS | 0.61 | -0.01 |
EPS Diluted | 0.61 | -0.01 |
Weighted Avg Shares Out | 21.56M | 21.56M |
Weighted Avg Shares Out (Dil) | 21.56M | 21.56M |
U.S. IPO Weekly Recap: Breast Cancer Biotech Pops 158% In A 6-IPO Week
Source: https://incomestatements.info
Category: Stock Reports